PSMA PET scan for newly diagnosed prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study looks at whether a special scan called PSMA PET can help predict how prostate cancer will progress. It is for people who have just been diagnosed and have not started treatment yet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with prostate cancer through a biopsy.
- You must have a PSMA PET scan before starting any treatment.
- You must be willing to have your health followed for at least 2 years.
- You cannot have had any treatment for prostate cancer before the scan.
- You cannot have another type of cancer that has spread.
- You cannot have neuroendocrine prostate cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special type of imaging scan (PSMA PET) to track how well prostate cancer treatment is working by comparing scans before and after your planned therapy. The goal is to help doctors better understand which treatments work best for your type of cancer.
This study tests whether a special type of imaging scan (PSMA PET/CT with delayed imaging) can better identify aggressive prostate cancer in men who haven't had a biopsy yet. The goal is to help doctors decide who really needs a biopsy and avoid unnecessary procedures.
This trial looks at how well a special scan called PSMA PET/CT can help find the spread of prostate cancer when it is first diagnosed. You may be able to join if your doctor has already recommended this scan for you.
This study uses a special type of scan called a PSMA PET to see how well different prostate cancer treatments are working. It is for people with advanced prostate cancer who are about to start or change systemic therapy.
This study uses a special type of PET scan called PSMA PET to better understand and track prostate cancer. The scan helps doctors see where the cancer is in the body and if treatment is working.
This study is looking at how well a special type of PET/CT scan (called PSMA PET/CT) can see cancer in people who have or may have certain tumors. It may help doctors better understand and track the disease.
Hear when a new Newly Diagnosed, Treatment-naïve Prostate Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.